| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRSR | Common Stock | Tax liability | $10,856 | -800 | -0.39% | $13.57 | 205,247 | 01 Jan 2023 | Direct | |
| transaction | CRSR | Common Stock | Tax liability | $50,263 | -3,704 | -1.8% | $13.57 | 201,543 | 02 Jan 2023 | Direct | F1 |
| transaction | CRSR | Common Stock | Sale | $70,000 | -5,000 | -2.5% | $14.00 | 196,543 | 04 Jan 2023 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRSR | Stock Option (Right to Buy) | Award | $0 | +258,324 | $0.000000 | 258,324 | 02 Feb 2022 | Common Stock | 258,324 | $19.72 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Includes 51,592 restricted stock units. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | This option was originally reported on a Form 4 filed by the Reporting Person on February 4, 2022. However, due to an inadvertent error, the Form 4 incorrectly reported the number of shares acquired. This option is being re-reported solely to correct the aforementioned error. Except as noted in this footnote, all other information as disclosed in the Reporting Person's original Form 4 was accurately reported. |
| F4 | The options vest and become exercisable as to 25% of the total shares on January 2, 2023; and as to 1/48th of the total shares monthly thereafter, subject to continued service through each such vesting date. |